NanoViricides Inc. (NNVC)

[JG36]

The only sources of money that don't involve giving away part of the profits in license agreements require vast amounts of further share dilution. Something you as an existing share holder should not be too keen on. And yes, most likely it will be a licensing agreement with a big pharmaceutical company rather than an outright buyout of NNVC. Me, I'd see such a agreement as a very positive result. It could ensure enough money to make NNVC profitable and also enable the development of other viricides that NNVC could retain full profits on, as it could then afford to do the trials on its own if it wants too.